A novel duplication polymorphism in the FANCApromoter and its association with breast and ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel duplication polymorphism in the FANCApromoter and its association with breast and ovarian cancer

Published:2005-04-29 Issue:1 Volume:5 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Thompson Ella,Dragovic Rebecca L,Stephenson Sally-Anne,Eccles Diana M,Campbell Ian G,Dobrovic Alexander

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-5-43.pdf

Reference20 articles.

1. Fujiwara Y, Tatsumi M, Sasaki M: Cross-link repair in human cells and its possible defect in Fanconi's anemia cells. J Mol Biol. 1977, 113: 635-649. 10.1016/0022-2836(77)90227-3.

2. D'Andrea AD, Grompe M: The Fanconi anaemia/BRCA pathway. Nat Rev Cancer. 2003, 3: 23-34. 10.1038/nrc970.

3. Hussain S, Witt E, Huber PA, Medhurst AL, Ashworth A, Mathew CG: Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum Mol Genet. 2003, 12: 2503-2510. 10.1093/hmg/ddg266.

4. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, Ikeda H, Fox EA, D'Andrea AD: Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 2002, 297: 606-609. 10.1126/science.1073834.

5. Dutrillaux B, Gerbault-Seureau M, Zafrani B: Characterization of chromosomal anomalies in human breast cancer. A comparison of 30 paradiploid cases with few chromosome changes. Cancer Genet Cytogenet. 1990, 49: 203-217. 10.1016/0165-4608(90)90143-X.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA repair pathways in breast cancer: from mechanisms to clinical applications;Breast Cancer Research and Treatment;2023-06-08

2. A model and cooperative co-evolution algorithm for identifying driver pathways based on the integrated data and PPI network;Expert Systems with Applications;2023-02

3. Clinical Benefit With PARP Inhibitor for Pathogenic Germline FANCA-Mutated Relapsed Epithelial Ovarian Cancer: A Case Report;Frontiers in Oncology;2022-02-25

4. DNA damaging agents and DNA repair: From carcinogenesis to cancer therapy;Cancer Genetics;2021-04

5. Genome-wide association study of recurrent endometriosis related with ovarian cancer;Clinical and Experimental Obstetrics & Gynecology;2019-08-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3